Tuma SeJean, Sepkowitz Kent A
Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Clin Infect Dis. 2006 Apr 15;42(8):1159-70. doi: 10.1086/501456. Epub 2006 Mar 15.
Nearly 6 years have passed since the Needlestick Safety and Prevention Act of 2000 was signed into law. We reviewed studies published since 1995 that evaluated the effect of safety-engineered device implementation on rates of percutaneous injury (PI) among health care workers. Criteria for inclusion of studies in the review were as follows: the intervention used to reduce PIs was a needleless system or a device with engineered sharps-injury protection, the outcome measurements included a PI rate, the intervention was evaluated in a defined population with clear comparison groups in clinical settings, and outcomes and denominators used for rate calculations were objectively measured using consistent methodology. All 17 studies reported substantial decreases in device-associated or overall PI rates after device implementation (range of reduction, 22%-100%). The majority of studies (n=12) were uncontrolled before-after trials with limited ability to control for confounding variables. In addition, implementation of safety-engineered devices was often accompanied by other interventions, and direct measurement of outcomes was not performed. Nevertheless, safety-engineered devices are an important component in PI prevention.
自2000年《针刺安全与预防法案》签署成为法律以来,已过去近6年时间。我们回顾了1995年以来发表的研究,这些研究评估了安全设计装置的实施对医护人员经皮损伤(PI)发生率的影响。纳入该综述的研究标准如下:用于减少经皮损伤的干预措施为无针系统或带有锐器损伤防护设计的装置;结果测量指标包括经皮损伤发生率;干预措施在临床环境中针对明确的对照群体在特定人群中进行评估;用于发生率计算的结果和分母采用一致的方法进行客观测量。所有17项研究均报告称,在装置实施后,与装置相关的或总体经皮损伤发生率大幅下降(下降幅度为22% - 100%)。大多数研究(n = 12)为前后对照的非对照试验,控制混杂变量的能力有限。此外,安全设计装置的实施通常还伴随着其他干预措施,且未对结果进行直接测量。尽管如此,安全设计装置仍是预防经皮损伤的重要组成部分。